832
Views
10
CrossRef citations to date
0
Altmetric
Laboratory Studies

Protective effects of irbesartan and alpha lipoic acid in STZ-induced diabetic nephropathy in rats

, , , , &
Pages 498-505 | Received 09 Dec 2009, Accepted 11 Jan 2010, Published online: 06 May 2010

REFERENCES

  • Rohrbach DH, Wagner CW, Star VL, Martin GR, Brown KS, Yoon JW. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin induced diabetic mice. J Biol Chem. 1983;258:11672–11677.
  • Ihm CG, Lee GS, Nast CC, Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int. 1992;41:768–777.
  • Reddi AS, Nimmagadda VR, Arora R. Effect of antihypertensive therapy on renal artery structure in type 2 diabetic rats with hypertension. Hypertension. 2001;37:1273–1278.
  • Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–878.
  • Lewis EJ, Hunsicker LG, Clarke WR, Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–860.
  • Carreau JP. Biosynthesis of lipoic acid via unsaturated fatty acids. Methods Enzymol. 1979;62:152–158.
  • Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med. 1995;19:227–250.
  • Melhem MF, Craven PA, De Rubertis FR. Effects of dietary supplementation of α-lipoic acid on early glomerular injury in diabetes. J Am Soc Nephrol. 2001;12:124–133.
  • Kanter M, Meral I, Yener Z, Ozbek H, Demir H. Partial regeneration/proliferation of the ß-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med. 2003;201:213–219.
  • Kanter M, Coskun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and ß-cell damage in streptozotocin-induced diabetic rats. Anat Rec. 2004;279:685–691.
  • Hsu SM, Raine L, Fanger H. Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577–580.
  • Collart F. Kidney failure, proteinuria, and diabetic nephropathy. Rev Med Brux. 2003;24:A257–A262.
  • Kreisberg JI, Garoni JA, Radnik R, Ayo SH. High glucose and TGFβ1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int. 1994;46:1019–1024.
  • Attisano L, Wrana JL. Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev. 1996;7:327–339.
  • August P, Suthanthiran M. Transforming growth factor β signaling, vascular remodeling, and hypertension. N Engl J Med. 2006;354:2721–2723.
  • Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331:1286–1292.
  • Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW. TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression. Kidney Int. 1999;56: 1710–1720.
  • Border WA, Noble NA. Cytokines in kidney disease: The role of transforming growth factor β. Am J Kidney Dis. 1993;22: 105–113.
  • Poncelet AC, Schnaper HW. Regulation of human mesangial cell collagen expression by transforming growth factor-β1. Am J Physiol. 1998;275:F458–F466.
  • Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A. 1993;90:1814–1818.
  • Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima fatty rats. Hypertension. 1997;29:728–735.
  • Shankland SJ, Scholey JW. Expression of transforming growth factor β1 during diabetic renal hypertrophy. Kidney Int. 1994;46:430–442.
  • Hellmich B, Schellner M, Schatz H, Pfeiffer A. Activation of transforming growth factor-β1 in diabetic kidney disease. Metabolism. 2000;49:353–359.
  • Kreisberg JI, Ayo SH. The glomerular mesangium in diabetes mellitus. Kidney Int. 1993;43:109.
  • Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int. 1999;56:1627–1637.
  • Leehey DJ, Singh AK, Alavi N, Singh R. Role of angiotensin II in diabetic nephropathy. Kidney Int. 2000;58:S93–S98.
  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–1462.
  • Cao Z, Bonnet F, Davis B, Allen TJ, Cooper ME. Additive hypotensive and anti-albuminuric effects of angiotensin-coverting enzyme inhibition and angiotensin receptor antagonist in diabetic spontaneously hypertensive rats. Clin Sci. 2001;100:591–599.
  • Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251–287.
  • Steckelings UM, Kaschina E, Unger T. The AT2 receptor – a matter of love and hate. Peptides. 2005;26:1401–1409.
  • Song KH, Lee WJ, Koh JM, Alpha-lipoic acid prevents diabetes mellitus in diabetes-prone obese rats. Biochem Biophys Res Commun. 2005;326:197–202.
  • Lee WJ, Song KH, Koh EH, Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun. 2005;332:885–891.
  • Kim MS, Park JY, Namkoong C, Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med. 2004;10:727–733.
  • Melhem MF, Craven PA, Liachenko J, DeRubertis FR. Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol. 2002;13:108–116.
  • Morcos M, Borcea V, Isermann B, Effect of α-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: An exploratory study. Diabetes Res Clin Pract. 2001;52:175–183.
  • Budisavljevic MN, Hodge L, Barber K, Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol. 2003;285: F1138–F1148.
  • Oksala NK, Lappalainen J, Laaksonen DE, Alpha-lipoic acid modulates heat shock factor-1 expression in streptozotocin-induced diabetic rat kidney. Antioxid Redox Signal. 2007; 9:497–506.
  • Ishii N, Patel KP, Lane PH, Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12(8):1630–1639.
  • Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol. 2000;11(1):71–79.
  • Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ. Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol. 2009;29:274–282.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.